世界の淋病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gonorrhea Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2612 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、淋病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・淋病治療の市場動向 ・企業の競争状況、市場シェア ・淋病治療の種類別市場規模（単剤療法、併用療法） ・淋病治療の用途別市場規模（クリニック、病院、その他） ・淋病治療の北米市場規模2016-2027（アメリカ、カナダ） ・淋病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・淋病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・淋病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・淋病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bharat Pharmaceuticals、GlaxoSmithKline、Merck、Pfizer、Alopexx Pharmaceuticals、AstraZeneca、Debiopharm Group、Melinta Therapeutics） ・結論

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.
The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.

Market Analysis and Insights: Global Gonorrhea Therapeutics Market
The global Gonorrhea Therapeutics market size is projected to reach US$ 1372.8 million by 2026, from US$ 1040 million in 2019, at a CAGR of 4.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gonorrhea Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gonorrhea Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gonorrhea Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gonorrhea Therapeutics market.

Global Gonorrhea Therapeutics Scope and Market Size
Gonorrhea Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gonorrhea Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Dual Therapy

Segment by Application
Clinics
Hospitals
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bharat Pharmaceuticals
GlaxoSmithKline
Merck
Pfizer
Alopexx Pharmaceuticals
AstraZeneca
Debiopharm Group
Melinta Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Dual Therapy
1.3 Market by Application
1.3.1 Global Gonorrhea Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gonorrhea Therapeutics Market Perspective (2016-2027)
2.2 Gonorrhea Therapeutics Growth Trends by Regions
2.2.1 Gonorrhea Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gonorrhea Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gonorrhea Therapeutics Industry Dynamic
2.3.1 Gonorrhea Therapeutics Market Trends
2.3.2 Gonorrhea Therapeutics Market Drivers
2.3.3 Gonorrhea Therapeutics Market Challenges
2.3.4 Gonorrhea Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Therapeutics Players by Revenue
3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2020
3.5 Gonorrhea Therapeutics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Therapeutics Product Solution and Service
3.7 Date of Enter into Gonorrhea Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gonorrhea Therapeutics Breakdown Data by Type
4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gonorrhea Therapeutics Breakdown Data by Application
5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gonorrhea Therapeutics Market Size (2016-2027)
6.2 North America Gonorrhea Therapeutics Market Size by Type
6.2.1 North America Gonorrhea Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gonorrhea Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gonorrhea Therapeutics Market Size by Type (2016-2027)
6.3 North America Gonorrhea Therapeutics Market Size by Application
6.3.1 North America Gonorrhea Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gonorrhea Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gonorrhea Therapeutics Market Size by Application (2016-2027)
6.4 North America Gonorrhea Therapeutics Market Size by Country
6.4.1 North America Gonorrhea Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gonorrhea Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gonorrhea Therapeutics Market Size (2016-2027)
7.2 Europe Gonorrhea Therapeutics Market Size by Type
7.2.1 Europe Gonorrhea Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gonorrhea Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gonorrhea Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gonorrhea Therapeutics Market Size by Application
7.3.1 Europe Gonorrhea Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gonorrhea Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gonorrhea Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gonorrhea Therapeutics Market Size by Country
7.4.1 Europe Gonorrhea Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gonorrhea Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gonorrhea Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gonorrhea Therapeutics Market Size (2016-2027)
9.2 Latin America Gonorrhea Therapeutics Market Size by Type
9.2.1 Latin America Gonorrhea Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gonorrhea Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gonorrhea Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gonorrhea Therapeutics Market Size by Application
9.3.1 Latin America Gonorrhea Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gonorrhea Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gonorrhea Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gonorrhea Therapeutics Market Size by Country
9.4.1 Latin America Gonorrhea Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gonorrhea Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gonorrhea Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bharat Pharmaceuticals
11.1.1 Bharat Pharmaceuticals Company Details
11.1.2 Bharat Pharmaceuticals Business Overview
11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.1.5 Bharat Pharmaceuticals Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Gonorrhea Therapeutics Introduction
11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gonorrhea Therapeutics Introduction
11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Alopexx Pharmaceuticals
11.5.1 Alopexx Pharmaceuticals Company Details
11.5.2 Alopexx Pharmaceuticals Business Overview
11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.5.5 Alopexx Pharmaceuticals Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Debiopharm Group
11.7.1 Debiopharm Group Company Details
11.7.2 Debiopharm Group Business Overview
11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.7.5 Debiopharm Group Recent Development
11.8 Melinta Therapeutics
11.8.1 Melinta Therapeutics Company Details
11.8.2 Melinta Therapeutics Business Overview
11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.8.5 Melinta Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Dual Therapy
Table 4. Global Gonorrhea Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gonorrhea Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gonorrhea Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gonorrhea Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Gonorrhea Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gonorrhea Therapeutics Market Share by Regions (2022-2027)
Table 10. Gonorrhea Therapeutics Market Trends
Table 11. Gonorrhea Therapeutics Market Drivers
Table 12. Gonorrhea Therapeutics Market Challenges
Table 13. Gonorrhea Therapeutics Market Restraints
Table 14. Global Gonorrhea Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gonorrhea Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2020)
Table 17. Ranking of Global Top Gonorrhea Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gonorrhea Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gonorrhea Therapeutics Product Solution and Service
Table 21. Date of Enter into Gonorrhea Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gonorrhea Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Gonorrhea Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gonorrhea Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gonorrhea Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gonorrhea Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Gonorrhea Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gonorrhea Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bharat Pharmaceuticals Company Details
Table 62. Bharat Pharmaceuticals Business Overview
Table 63. Bharat Pharmaceuticals Gonorrhea Therapeutics Product
Table 64. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bharat Pharmaceuticals Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gonorrhea Therapeutics Product
Table 69. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Gonorrhea Therapeutics Product
Table 74. Merck Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Gonorrhea Therapeutics Product
Table 79. Pfizer Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Alopexx Pharmaceuticals Company Details
Table 82. Alopexx Pharmaceuticals Business Overview
Table 83. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product
Table 84. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Alopexx Pharmaceuticals Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Gonorrhea Therapeutics Product
Table 89. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Debiopharm Group Company Details
Table 92. Debiopharm Group Business Overview
Table 93. Debiopharm Group Gonorrhea Therapeutics Product
Table 94. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Debiopharm Group Recent Development
Table 96. Melinta Therapeutics Company Details
Table 97. Melinta Therapeutics Business Overview
Table 98. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Melinta Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Dual Therapy Features
Figure 4. Global Gonorrhea Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Gonorrhea Therapeutics Report Years Considered
Figure 9. Global Gonorrhea Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Gonorrhea Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gonorrhea Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Gonorrhea Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Gonorrhea Therapeutics Market Share by Players in 2020
Figure 14. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2020
Figure 16. Global Gonorrhea Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Gonorrhea Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Gonorrhea Therapeutics Market Share by Region (2016-2027)
Figure 38. China Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 61. Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 63. Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 64. Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---